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Abstract
Introduction
Arteriovenous malformations (AVMs) are characterized by pathological high flow, low resis-
tance connections between arteries and veins. Treatment is critically dependent on correct
interpretation of angioarchitectural features. However, some microfistular AVMs do not
match the characteristics described in current AVM classification systems. Therefore, we
propose a new subgroup of microfistular AVMs, composed of enlarged, fistulous paths on
the venous half of capillaries and/or dilated draining venules (hyperdynamic, capillary-venu-
lous malformation [CV-AVM]). CV-AVMs still ensure arterial flow to the periphery and fistu-
lous venous drainage is less pronounced than in classical AVMs such that these lesions are
often misinterpreted as venous malformations.
Materials and methods
We developed a computational model to study the effects of microvascular anomalies on
local hemodynamics, as well as their impact on angiographic contrast propagation. Flow
rates and pressures were computed with a lumped parameter description, while contrast
propagation was determined by solving the 1D advection-diffusion equation.
Results and conclusions
For the newly proposed CV-AVM angioarchitecture, the computational model predicts
increased arterio-venous contrast agent transit times and highly dispersive transport char-
acteristics, compared to microfistular, interstitial type IV AVMs and high flow type II and III
AVMs. We related these findings to time-contrast intensity curves sampled from clinical
angiographies and found that there is strong evidence for the existence of CV-AVM.
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Introduction
Congenital vascular malformations are vascular anomalies, which arise during embryonic vas-
cular development and represent an inborn error of the normal vascular angioarchitecture.
Depending on the affected vascular systems, lesions are grouped into arterio-venous, venous,
capillary or lymphatic malformations [1].
Arterio-venous malformations (AVMs) are anomalous networks of high flow, low resis-
tance connections between arteries and veins, which bypass the capillary bed [2]. Beside clini-
cal aspects, AVMs are diagnosed using duplex ultrasound to assess arterial and venous flow
characteristics, non-invasive magnetic resonance (MR) imaging and catheter based intra-arte-
rial digital subtraction angiography (DSA). For detailed AVM specification, DSA with arterial
injection of contrast agent (CA) and simultaneous observation of CA spread in the malforma-
tion remains the gold standard for diagnosis (Fig 1). The presence of an AVM causes rapid
spread of CA in the arterial system, as well as an early and non-dispersed venous drainage.
AVMs can be classified into different types according to their angioarchitecture. The Yakes
classification [3] is a recent adjustment of the nomenclature that builds on previously reported
AVM morphology descriptions [4,5]. Yakes differentiates four basic types of AVMs depending
on their angioarchitecture and observed hemodynamic behavior [2]. Yakes type I AVM
describes a single shunt between an artery and a vein. Type II is a complex tangle of small-
sized abnormal blood vessels (nidus) with several feeding arteries and draining veins. Type
IIIa/b are described as multiple feeding arteries draining via the wall of an aneurysmal vein to
single/multiple outflow veins (Fig 1, left column). In type I-III AVMs, no intervening capillary
bed is present. Increased venous pressures and high flow rates in the malformation often lead
to a complete lack of parallel capillary perfusion (arterial steal). Yakes also reports on AVM
variants with an abnormality in the microcirculation (interstitial type IV, Fig 1, middle col-
umn). Type IV AVMs are composed of anomalous connections between arterioles and venules
that are interwoven with normal capillaries, which maintain the viability of surrounding tissue.
Clinical presentation is similar to type I-III AVMs, although no clear angiographic nidus is vis-
ible on DSA, but rather a dense contrast blush. Moreover, hemodynamic changes are less dra-
matic and venous shunt flow is delayed compared to type I-III AVM [2,3].
At the other end of the spectrum are venous malformations. They are low-flow congenital
malformations composed of thin-walled, dilated veins [6]. Blood flow is extremely slow and
can become stagnant [7,8].
Although most malformations can be classified into one of the presented lesion types, some
lesions do not present typical features and cannot be associated with a known lesion type [9].
Over the past decade, the Division of Angiology of the University Hospital Bern has treated a
significant number of patients with congenital vascular malformations exhibiting characteris-
tics of type IV AVMs together with features that are commonly associated with venous malfor-
mations. DSA recordings show diffuse, “cloudy” regions of CA accumulation similar to type
IV AVMs, but venous drainage is more delayed and dispersed (Fig 1, right column). The
regional accumulation of CA and partially elevated arterial flow suggests the presence of a
hyperdynamic path with low vascular resistance between the arterial and venous system,
although venous drainage pattern is untypical for classical high-flow AVMs.
We hypothesize that there exists a hyperdynamic, capillary-venulous (CV-AVM) subgroup
of “microfistular” AVMs composed of fistulous paths on the venous half of capillaries and/or
dilated draining venules (hyperdynamic, capillary-venulous malformation [CV-AVM]). The
pathologic pressure gradient in CV-AVMs still ensures normal arterial flow to the periphery
with fistulous venous drainage that is less pronounced compared to classical AVMs. To test
the hypothesis, we developed a computational hemodynamic model that allows studying the
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theoretical effects of microvascular anomalies, such as CV-AVM and type IV AVMs, on local
blood velocities, flow rates as well as their impact on CA propagation, with special emphasis
on CA transit times and dispersion. The computational findings are compared to clinical
observations to determine if the hypothesized microvascular malformation morphologies can
explain the pathological CA transport patterns measured in patients.
Materials and methods
Microcirculation and AVM graph models
A model representing the microcirculation in skeletal muscle was developed to study the effects
of morphological abnormalities in the microvasculature on hemodynamic parameters and
arterio-venous CA transport. Clinical observations suggest that microvascular malformations
Fig 1. DSA recordings of AVM cases. Arterial (upper row) and venous phases (bottom row) in DSA recordings of patients diagnosed with Yakes type
IIIb (left column), Yakes type IV (middle column) and hyperdynamic CV-AVMs (right column).
https://doi.org/10.1371/journal.pone.0203368.g001
Angioarchitecture and hemodynamics of microvascular AVMs
PLOS ONE | https://doi.org/10.1371/journal.pone.0203368 September 7, 2018 3 / 14
can affect large tissue regions, which cannot be represented in a computational model, due to
their complexity and associated high computational costs. Therefore, we study microvascular
CA transport on an isolated tissue slab, which contains a fully resolved capillary bundle element
with penetrating transverse arterioles and collecting venules (Fig 2).
The arteriolar and venular trees are constructed according to average values for vessel
dimensions and tree topology [10,11]. Arterial and venous distensibility values are assigned to
the vessel segments according to Gamble and Be´rczi [12,13]. Similarly, we build a capillary
bundle element following statistical data on the connectivity of skeletal muscle microcircula-
tion vessels introduced by Skalak et al. [11,14]. Vessel dimensions (i.e. segmental diameter and
lengths) are randomly sampled from the reported distributions. Capillary distensibility is cho-
sen according to Skalak [15], with slightly decreased/increased values for segments near the
feeding arteriole and draining venule, respectively. The resulting networks contain 108 nodes
and 175 segments, where 11/18 segments are part of the arteriolar/venular tree and 146 edges
correspond to capillary segments.
Starting from 25 random physiological reference configurations, we introduce two types of
microvascular malformation morphologies, Yakes type IV AVM (Fig 2B) and hyperdynamic
CV-AVM (Fig 2C). Type IV AVMs are built by randomly sampling pairs (n 2 {4,6,8}) of
MVA VI epyTenilesaB
CV-AVM
Ain Ain
Ain
Vout Vout
Vout
Inlet
arteriole
Outlet 
venuleCapillary bed
A B
C
Fig 2. Prototype capillary bundle elements and microvascular AVMs. Schematic representation of a capillary bundle
element with feeding arteriole and draining venule. (A) Baseline: physiological reference condition; (B) Type IV: example
of Yakes type IV AVM; (C) CV-AVM: hypothesized morphology of a hyperdynamic CV-AVM.
https://doi.org/10.1371/journal.pone.0203368.g002
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arteriolar and venular nodes from a uniform distribution. The segmental length and disten-
sibility of these additional connections are defined as the average length and distensibility of
the vessels being connected by the malformation, while their diameter corresponds to double
the average diameter of the connected vessels. CV-AVMs are built by increasing the diameter
of the draining venular tree (xfactor 2 {2,3,4}) and introducing a set of additional connections
(n 2 {2,4,6,8}) between the arterial half of the capillary bundle and the venular nodes. These
additional connections may represent the presence of abnormal connections and/or enlarged
pathways in the venous capillaries. The node pairs are randomly sampled from a uniform dis-
tribution and their geometric and mechanical properties are defined following the same strat-
egy as in type IV AVMs.
In all cases, the ranges for n and xfactor are chosen such that the resulting hemodynamic
behavior differs substantially from the physiological reference state and such that it covers the
hemodynamic parameter ranges observed in patients. The factors for venular dilation xfactor in
CV-AVMs are additionally motivated by observations made in large scale, congenital venous
anomalies [16]. Since statistical data on the morphometry of microvascular AVMs is not avail-
able, we choose equidistant samples within the limits of the ranges.
Blood flow and substance transport modelling
Blood flow and CA transport within the microvascular networks are computed with the strate-
gies described in our previous study on peripheral AVMs [17]. In brief, blood flow is simulated
with a lumped parameter approach, where the Navier-Stokes equations [18] are averaged in
space over each segment of the network (lumped element). This results in a set of ordinary dif-
ferential equations in time for each segment. The segments are coupled by enforcing continu-
ity of pressure and conservation of mass at each node of the network. We account for the non-
Newtonian behavior of blood in microcirculatory networks by adjusting the apparent viscosity
for vessel diameter and local hematocrit [19] using the relation by Pries [20] and empirical
data by Lipowsky [21].
At the arteriolar inlet and venular outlet nodes we imposed pressure boundary conditions,
which were obtained from a computational model for a physiological reference configuration
[17] by probing the pressures in the pre- and post-capillary elements. The inlet pressure has a
systolic/diastolic value of 60/57 mmHg, while the outlet pressure is nearly constant at approxi-
mately 13 mmHg. The left and right boundary nodes of the bundle elements (filled and empty
circles in Fig 2) are connected with an additional boundary segment, which results in periodic
boundary conditions and mimics an infinitely long capillary bundle with alternating penetrat-
ing arterioles and venules.
CA transport is determined by solving the 1D advection-diffusion equation on the sub-
divided network, based on interpolated advection velocities and a diffusion coefficient describ-
ing binary molecular diffusion of iodinated contrast agent in blood [17]. At the CA injection
site (node Ain, Fig 2), we apply a typical temporal CA injection profile sampled from DSA
recordings (cf. next section), whereas convective outflow conditions [22] are imposed at the
venular outlet node (Vout, Fig 2).
DSA sampling
The computational results are compared to DSA recordings of patients diagnosed with a con-
genital microvascular AVM type IV or hyperdynamic CV-AVM. As a reference, we also
include angiograms of patients diagnosed with Yakes type II and type IIIa/b AVMs. Non-path-
ological baseline angiograms were not included as visualizing of the venous phase after arterial
CA injection in the healthy vasculature tree would require high contrast and radiation doses,
Angioarchitecture and hemodynamics of microvascular AVMs
PLOS ONE | https://doi.org/10.1371/journal.pone.0203368 September 7, 2018 5 / 14
because healthy tissue has many vascular pathways with slightly different path lengths, yielding
very low contrast signals reaching the venous system.
All patient data were obtained from the VASCOM (VAScular COngenital Malformation)
registry. All patients gave written informed consent and the study was approved by the Ethics
Committee of the Canton of Bern (local ethics board number 2016–01503).
Arterial and venous CA concentration and intensity curves are sampled at nodes Ain and
Vout of the computational models and at specific locations in DSA recordings. The considered
malformations are confined to the same anatomical region (foot) and all intensity curves are
sampled at similar locations (0–15 cm above the lateral malleolus). For DSA sampling, we
select small regions of interest (ROIs) that contain a segment of each feeding artery and drain-
ing vein (Fig 3). For each temporal frame, the intensity values contained in all arterial/venous
ROIs are summed up and divided by the number of non-zero pixels. When overlapping arter-
ies and veins are present, venous sampling is started only when the arterial signal vanishes.
This way, we obtain an equivalent inlet and outlet time-concentration curve that can be used
for further analysis. Note that this concentration refers to normalized pixel intensities, rather
than the chemical concentration of a substance. The two quantities are proportional within the
linear operating range of the image acquisition device.
Data analysis
The comparison of computational results and in-vivo data is performed by means of the param-
eters of a transport operator (TOp) or transfer function, which translates the CA concentration
curve sampled at the arterial inlet into the concentration at the venous outlet. The TOp is based
on a differential operator for vascular transport phenomena introduced by King [23]. It is com-
posed of a delay (modelling advection) and a fourth order differential operator (modelling dis-
persion and diffusion), which has the shape of a skewed unimodal distribution. The TOp
parameters are optimized with a least-squares algorithm [24], such that the output of the TOp
approaches the computed and measured venous concentration curves. The first and second
Vout samplingAin sampling
t = 1.5 s t = 20 s 
BA
Fig 3. Example of concentration measurements in DSA recordings. (A) Arterial and venous sampling ROIs, (B) normalized CA intensity evolution for
ROIs depicted in A.
https://doi.org/10.1371/journal.pone.0203368.g003
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central moments of the fitted TOp are used as representative parameters for the advective and
dispersive behavior of the considered vasculature and will be termed arterio-venous delay td
(first moment) and absolute dispersivity AD (square root of second moment) in the following.
TOps for the computational models describe transport phenomena on the microscopic
scale. In contrast, TOps fitted to DSA recordings also include the dispersivity and delay intro-
duced by the macroscopic circulation, which results in different time scales for td and AD. To
compare the different TOps, we normalize td and AD with the characteristic network turnover
time tc, defined as the ratio of the total vessel volume Vtot between the sampling points and the
total volumetric flow rate Qtot in healthy individuals. For computational models, the calcula-
tion of tc is straightforward, because Vtot and Qtot can be determined from the model descrip-
tion and blood flow calculations. For patient data, representative values for Vtot and Qtot were
obtained from literature [25–28].
Results
Hemodynamic analysis
Computed blood flow velocities and volumetric flow rates are shown in Fig 4 for all investi-
gated physiological baseline configurations, for type IV AVMs and for hyperdynamic
CV-AVMs.
For baseline networks, velocities in the inlet arteriole are in the range 7.6–9.5 mm/s and
3.6–4.6 mm/s in the outlet venule. The average velocities within the capillary bed lie in the
range 2–2.5 mm/s.
A type IV AVM increases the velocity in proximal arterioles and venules, while capillary
velocities and flow rates are decreased with respect to baseline conditions. The increase in arte-
riolar and venular flow and the reduction in capillary perfusion is stronger, the larger the num-
ber of fistulae and the more proximal the location of the shunts. Velocities and flow rates in
the malformation also depend strongly on the size, location and number of shunting vessels
and are 3.7–58 mm/s and 0.02–0.36 μl/min, respectively.
For hyperdynamic CV-AVMs, the inlet arteriole can exhibit increased velocity values with
respect to the baseline configuration. However, outlet venule velocities are consistently smaller
than in type IV and baseline networks, whereas the flow rates are mostly higher than the base-
line. Capillary flow rates and velocities can be similar to the non-pathological vasculature for a
small number of microfistulae, shunts feeding from distal capillary nodes and for little venular
dilation. More severe malformations reduce the velocities and flow rates in the capillaries.
Velocities and flow rates in the fistulous vessels are 1.4–10 mm/s and 0.008–0.04 μl/min,
respectively.
CA transport and radiographic analysis
Arterio-venous transport patterns in computational and clinical results are compared to relate
specific microvascular AVM morphologies to their manifestation in diagnostic DSA images.
Fig 5 shows CA concentration near the arterial injection site and the resulting venous return
for different types of microvascular AVMs and the baseline configuration. The curves illustrate
the main effects of the malformations investigated in this study. Type IV malformations
exhibit a faster and less dispersive arterio-venous CA transport than CV-AVMs, which is
reflected by a smaller distance between the arterial injection profile and the venous return
curve (small td) and by the smaller broadening of the curve (small AD). In contrast, CV-AVMs
exhibit a larger delay between arterial injection and venous return, while the venous profile-
width is strongly increased (higher dispersivity).
Angioarchitecture and hemodynamics of microvascular AVMs
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Fig 6 shows arterial and venous CA intensities obtained from DSA recordings of microvas-
cular AVMs and, for comparison, of a classical type IIIb AVM. Type IIIb shows an even faster
and less dispersive behavior than type IV, and the CV-AVM is again the slowest and most dis-
persive malformation. The DSA recordings were stopped shortly after the peaking of the
venous CA return to limit radiation dosage. The classification of these cases corresponds to the
existing clinical diagnosis, which is based on DSA and duplex ultrasound recordings (as
described in the first section of the manuscript). Although the clinical diagnosis of microfistu-
lar AVMs with strongly delayed and dispersed venous CA appearance (CV-AVM) already
exists, the morphology of these AVMs is unknown. The purpose of this study is to determine if
the hypothesized angioarchitecture leads to the abnormal arterio-venous CA transport pat-
terns observed in patients (e.g. the behavior shown in Fig 6). Note that the time scales in Figs 5
and 6 are different due to the different sampling vessels (cf. Materials and methods).
eloiretra telnIeloiretra telnI
seirallipaCseirallipaC
ealutsiFealutsiF
elunev teltuOelunev teltuO
Fig 4. Hemodynamic parameters of computational AVM models. Temporal mean of blood flow velocities (left column) and flow rates (right
column) in the inlet arteriole (first row), capillary bed (second row, mean value over all capillaries), fistulous vessels (third row, maximum value
over all fistulae) and outlet venule (fourth row) for all computed prototypes. Each solid line represents one prototype baseline (green), type IV
(orange) and type CV (blue) configuration.
https://doi.org/10.1371/journal.pone.0203368.g004
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Venous return curves are highly dependent on the precise shape of the injection curves. A
quantitative comparison of the venous return curves among different patients is therefore dif-
ficult. Instead, we compare the TOp parameters td and AD of different AVMs, which have
been determined from the corresponding CA curves. The coefficient of determination r2
achieved for shown computational TOps lies above 0.98, while TOps fitted to clinical measure-
ments yield r2>0.97, when applying the operator to the arterial curve and comparing the out-
put (dashed curves in Figs 5 and 6) to the computed/measured venous curve.
Fig 7 shows scaled td and AD values of computational (triangles) and clinical cases (circles).
Computational results (triangles in Fig 7) show that type IV AVMs exhibit AD values in the
td = 0.09 s
AD = 0.08 s 
td = 0.49 s
AD = 0.26 s 
td = 1.29 s
AD = 0.58 s 
Fig 5. CA concentration at inlet and outlet nodes of computational AVM models. Temporal evolution of CA concentration at the injection
point Ain (red curve) and at the venular outlet node Vout of computational prototypes for baseline conditions (green), type IV (orange) and CV
(blue) AVMs. The dashed black lines represent the output of the fitted TOp for each configuration.
https://doi.org/10.1371/journal.pone.0203368.g005
td = 7.6 s
AD = 1.2 s 
td = 12.6 s
AD = 3.3 s td = 29.8 s
AD = 23.2 s 
Fig 6. Analysis of DSA recordings of AVM patient cases. The dots on the solid curves represent sampled arterial (red) and venous (grey for type
IIIb, orange for type IV and blue for CV-AVM) equivalent concentration values, while the dashed black line shows the corresponding fitted TOp
output.
https://doi.org/10.1371/journal.pone.0203368.g006
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range of 0.1–0.8 and td < 1. In this case, all AD values above 0.4 (and td > 0.4) are observed in
type IV models, where fistulae are either small in number or feeding from distal nodes of the
arteriolar tree. CV-AVMs result in td 1 and AD 0.3. All CV-AVM cases with similar AD
values as the baseline (0.3 AD 0.8) correspond to model networks with small venular dila-
tion (i.e. xfactor < 3). At the other end of the parameter range, AD and td can become arbitrarily
large, when increasing the diameter of the draining venules to unphysiologically large values.
Baseline td values mostly lie around 1 and AD lies between 0.4–0.8. Computations by Frey
et al. [17] for large scale type IIIb AVMs exhibit extremely small AD and td values around
0.02–0.03 and 0.05–0.1, respectively. In-vivo measurements of all malformation types (circles
in Fig 7) perfectly fit into the reported computational ranges.
In summary, CV-AVMs are characterized by large td and AD values, while type IV show
smaller CA dispersion and delay. Type II and III AVMs thereby show an even faster and less
dispersive shunting behavior than type IV AVMs.
Discussion
This study confirms that different types of CA transport patterns observed in AVM patients
are a consequence of intrinsic differences in lesion angioarchitecture. Differences in these pat-
terns have been quantified both with computational models and by analyzing contrast propa-
gation in diagnostic DSA recordings. We found strong evidence for the existence of a
microvascular, hyperdynamic CV-AVM, which is different from any AVM angioarchitecture
described so far. Our results show that the hypothesized CV-AVM morphology of enlarged,
fistulous paths on the venous half of capillaries and/or dilated draining venules accurately
describes the phenomena observed in patients.
Patient
Simulation
CV-AVM
No AVM
Type IV AVM
Type II/III AVM
Fig 7. AD and td values for computational AVM models and patient cases. Scaled AD (absolute dispersion) and td
(total delay) for baseline (green triangles), type IIIb (grey triangles), type IV (orange triangles), type CV (blue triangles)
and type IIIb (grey triangles) computational models (n = 315) and type IV (orange circles), type CV (blue circles) and
type I/III (grey circles) patient cases (n = 10).
https://doi.org/10.1371/journal.pone.0203368.g007
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Computed blood flow velocity ranges obtained with our model of fully resolved capillary
bundles with penetrating transverse arterioles and collecting venules are in good agreement
with the values reported in literature. Typical velocities measured in mammal arterioles are in
the range 5–10 mm/s, while venules exhibit values around 2–5 mm/s [11]. Capillary velocities
attain mean values around 2–3 mm/s [29]. These ranges fully contain the computational values
reported in this study. The agreement between baseline models and in-vivo values is crucial for
the predictive capacity of the model and strengthens the validity of the results. As stated above,
CA transit characteristics of the computational baseline may be suited to describe local phe-
nomena, but cannot accurately describe the strongly dispersive macroscopic behavior of non-
pathological vasculature, which consists of innumerable paths composed of similar capillary
bundles with similar morphological and hemodynamic characteristics. For this reason and
because of the lack of DSA recordings of healthy individuals, we restrict our analysis to the
comparison of different malformation types, without comparing the results to a macroscopic
physiological reference state.
The temporal evolution of CA concentration at the injection point and at the venular outlet
node Vout of the computational prototypes shows typical type IV and CV-AVM time-concen-
tration curves that clearly exemplify the two distinct CA transport patterns observed in both
computational and in-vivo results. CV-AVMs show a slow and dispersive shunting behavior,
while type IV AMVs are faster and remarkably less dispersive. These characteristic transport
patters are a direct consequence of the strongly differing hemodynamic behavior of the two
lesion types. For type IV AVMs, flow velocities in the proximal arterioles and venules are
increased due to the reduced vascular resistance caused by the additional, comparatively large
connections between arterioles and venules. The reduction of flow rates in the parallel capillar-
ies is a similar effect as the arterial steal [1] observed in larger AVMs, but on a smaller scale
and without compromising the viability of the surrounding tissue to the same degree, as perfu-
sion is mostly sustained [2,3]. Even so, flow rates and velocities in the malformation can be
several orders of magnitude higher than in the parallel capillary bed, which results in the
observed fast and only little dispersive shunting of CA. Thus, “steal” is large enough, such that
venous CA signals in type IV AVMs are mostly composed of the substance shunted through
the malformation. Since the malformation is composed of a lesser number of paths than the
capillary bed, dispersion is reduced. Additionally, the high velocities in the shunt result in
small CA advection times.
For hyperdynamic CV-AVMs, the overall vascular resistance is decreased due to the pres-
ence of fistulae in the capillary bed and the postulated enlargement of venules, which leads to
the increase in arteriolar velocities and flow rates. However, this effect is not as pronounced as
in type IV AVMs. Similarly, the presence of fistulae in the venous half of the capillary bed
reduces parallel capillary perfusion less strongly than in type IV lesions, which again ensures
the viability of surrounding tissue, a phenomenon also observed in patients. Fistulae in the
venous capillaries, though also representing a preferred, low resistance path for blood and CA,
act in a similar temporal and spatial scale as the parallel capillaries, which results in small
“steal” and increases dispersion since venous CA signals are composed of both CA transported
through healthy and diseased vessels (additional path length differences). The strong enlarge-
ment of venules, though causing an increase in volumetric blood flow rates (decreased resis-
tance), decreases the velocity in these vessels, amplifying dispersivity, while also increasing
advection time.
These observations clearly match the clinical presentations of type IV and CV-AVMs. The
former is characterized by increased arterial and venous flow rates and velocities, while the lat-
ter only shows little increase in arterial flow and a decrease in venous flow velocities due to the
enlarged venous diameter. The strikingly slow and dispersed venous drainage of CA in
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CV-AVMs is the main distinction criterion between CV-AVMs and other types of AVMs in
DSA recordings.
Fig 7 summarizes all CA transport patterns in terms of the scaled arterio-venous delay td
and the scaled absolute dispersivity of the intervening vasculature AD, which clearly shows an
accumulation of td and AD at high values for CV-AVMs and at lower values for type IV
lesions, independent of interpatient variability of other factors. If the malformations only con-
tain small changes to the physiological reference configuration, AD and td are in a similar
range as the baseline network models. As expected, in-vivo and computational type IIIb and II
AVMs both show an even faster and less dispersive CA shunting than most type IV lesions. In
all cases, computational results agree with their corresponding patient cases.
These new insights into microvascular AVM angioarchitectures may pave the way for more
efficient diagnostic processes as well as safer and more specific interventional treatment
options, reducing the patient’s exposure to contrast and radiation and most importantly, mini-
mizing the incidence of unidentified and mistreated lesions. Further clinical integration of
computational models will provide more powerful tools for precise disease identification and
hemodynamic specification of vascular pathologies.
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